Is KIN or QYLD a better dividend investment in 2026?

KIN currently yields 21.62% with a 5% 5-year dividend growth rate. QYLD yields 12.24% with -2.1% growth. The better choice depends on your goal: KIN offers higher current income.

What is the dividend yield difference between KIN and QYLD?

KIN has a forward dividend yield of 21.62% ($2.00/share annually). QYLD yields 12.24% ($2.04/share annually). The yield gap is 9.38 percentage points.

Home › Compare › KIN vs QYLD

KIN vs QYLD: Dividend Comparison 2026

KIN yields 21.62% · QYLD yields 12.24%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 KIN wins by $54.1K in total portfolio value

INVESTMENT

TIME HORIZON10 years

KIN

● Live price

21.62%

Share price

$9.25

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$80.6K

Annual income

$7,983.46

Full KIN calculator →

QYLD

Global X Nasdaq 100 Covered Call ETF

● Live price

12.24%

Share price

$16.70

Annual div

$2.04

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$26.5K

Annual income

$6,038.84

Full QYLD calculator →

Portfolio growth — KIN vs QYLD

📍 KIN pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	KIN	QYLD
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, KIN + QYLD cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

KIN pays

QYLD pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

KIN

Annual income on $10K today (after 15% tax)

$1,837.84/yr

After 10yr DRIP, annual income (after tax)

$6,785.94/yr

QYLD

Annual income on $10K today (after 15% tax)

$1,040.82/yr

After 10yr DRIP, annual income (after tax)

$5,133.01/yr

At 15% tax rate, KIN beats the other by $1,652.93/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of KIN + QYLD for your $10,000?

KIN: 50%QYLD: 50%

100% QYLD50/50100% KIN

Portfolio after 10yr

$53.6K

Annual income

$7,011.15/yr

Blended yield

13.08%

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

KIN buys

QYLD buys

No recent congressional trades found for KIN or QYLD in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricKINQYLD

Forward yield	21.62% ✓	12.24%
Annual dividend / share	$2.00	$2.04 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$80.6K ✓	$26.5K
Annual income after 10y	$7,983.46 ✓	$6,038.84
Total dividends collected	$47.7K ✓	$28.5K
Payment frequency	quarterly	monthly
Sector	Stock	ETF

Year-by-year: KIN vs QYLD ($10,000, DRIP)

Year	KIN Portfolio	KIN Income/yr	QYLD Portfolio	QYLD Income/yr	Gap
1← crossover	$12,862	$2,162.16	$10,384	$1,224.49	+$2.5K → KIN
2	$16,362	$2,599.07	$10,900	$1,388.18	+$5.5K → KIN
3	$20,597	$3,089.91	$11,576	$1,590.76	+$9.0K → KIN
4	$25,674	$3,635.27	$12,447	$1,844.20	+$13.2K → KIN
5	$31,706	$4,234.91	$13,567	$2,164.97	+$18.1K → KIN
6	$38,813	$4,887.76	$15,003	$2,576.05	+$23.8K → KIN
7	$47,122	$5,591.96	$16,853	$3,110.04	+$30.3K → KIN
8	$56,765	$6,344.91	$19,251	$3,813.85	+$37.5K → KIN
9	$67,882	$7,143.35	$22,390	$4,756.08	+$45.5K → KIN
10	$80,618	$7,983.46	$26,548	$6,038.84	+$54.1K → KIN

KIN vs QYLD: Complete Analysis 2026

KIN — Stock

Kindred Biosciences, Inc., a biopharmaceutical company, is developing biologics that focus on the lives of pets. The company has a pipeline of novel biologics in development across various therapeutic classes and intellectual property portfolio. Its programs under development include interleukin-31 and interleukin-4R for canine atopic dermatitis; KIND-030 for parvovirus in dogs; KIND-510a for the control of non-regenerative anemia in cats; anti-TNF antibody for inflammatory bowel disease in dogs; and other biologics candidates. The company was founded in 2012 and is headquartered in Burlingame, California.

Full KIN Calculator →

QYLD — ETF

The Global X Nasdaq 100 Covered Call ETF (QYLD) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Cboe Nasdaq-100 BuyWrite V2 Index.

Full QYLD Calculator →

📬

Get this KIN vs QYLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

KIN vs SCHD KIN vs JEPI KIN vs O KIN vs KO KIN vs MAIN KIN vs XYLD KIN vs JEPQ KIN vs RYLD

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.